Kevin C Soares
Overview
Explore the profile of Kevin C Soares including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
1779
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Blair A, Radomski S, Chou J, Liu M, Howell T, Park W, et al.
Ann Surg Oncol
. 2024 Nov;
32(3):1869-1878.
PMID: 39576455
Background: Pancreatic acinar cell carcinoma (pACC) is a rare neoplasm of the exocrine pancreas. There is a dearth of information about tumor characteristics and patient outcomes. This study describes the...
12.
Schleimer L, Hakki L, Seier K, Seo S, Cohen N, Usiak S, et al.
Ann Surg Oncol
. 2024 Nov;
32(2):1043-1053.
PMID: 39570297
Background: Surgical site infections (SSIs) are a major driver of morbidity after combined liver and colorectal surgery for metastatic colorectal cancer. Available literature is inadequate to characterize risk factors and...
13.
Keane F, OConnor C, Moss D, Chou J, Perry M, Crowley F, et al.
J Natl Cancer Inst
. 2024 Oct;
117(3):496-506.
PMID: 39460946
Background: Adjuvant modified leucovorin calcium, fluorouracil, irinotecan hydrochloride, and oxaliplatin (FOLFIRINOX) is standard of care for fit individuals with resected pancreatic ductal adenocarcinoma (PDAC). Data are limited on adjuvant modified...
14.
Karagkounis G, Horvat N, Danilova S, Chhabra S, Narayan R, Barekzai A, et al.
Ann Surg Oncol
. 2024 Oct;
31(13):9196-9204.
PMID: 39369120
Objectives: This study was designed to assess computed tomography (CT)-based radiomics of colorectal liver metastases (CRLM), extracted from posttreatment scans in estimating pathologic treatment response to neoadjuvant therapy, and to...
15.
Blair A, Soares K, Guerrero C, Drebin J, Jarnagin W, He J, et al.
HPB (Oxford)
. 2024 Sep;
26(12):1528-1535.
PMID: 39289133
Background: Adoption of robotic pancreatoduodenectomy (RPD) is growing, although there are challenges for safe introduction of this technique, including limitations in on-site expert proctoring. We developed and implemented a structured...
16.
Ecker B, Seier K, Eckhoff A, Tortorello G, Allen P, Balachandran V, et al.
JAMA Surg
. 2024 Sep;
159(12):1365-1373.
PMID: 39259526
Importance: Ampullary adenocarcinoma (AA) is characterized by clinical and genomic heterogeneity. A previously developed genomic classifier defined biologically distinct phenotypes with greater accuracy than standard histologic classification. External validation is...
17.
Habib J, Kinny-Koster B, Javed A, Zelga P, Saadat L, Kim R, et al.
J Clin Oncol
. 2024 Sep;
42(36):4317-4326.
PMID: 39255450
Purpose: The benefit of adjuvant therapy for intraductal papillary mucinous neoplasm (IPMN)-derived pancreatic ductal adenocarcinoma (PDAC) remains unclear because of severely limited evidence. Although biologically distinct entities, adjuvant therapy practices...
18.
Schleimer L, Kalvin H, Ellis R, Kingham T, Soares K, DAngelica M, et al.
Ann Surg Oncol
. 2024 Jul;
31(10):6551-6563.
PMID: 39042229
Background: Management of intrahepatic cholangiocarcinoma (IHC) has advanced in recent decades, including randomized trial evidence supporting systemic therapy in the palliative and adjuvant setting. Mounting observational evidence suggests resection of...
19.
Preston W, Drill E, Boerner T, Gelfer R, Harding J, OReilly E, et al.
JCO Precis Oncol
. 2024 Jul;
8:e2400206.
PMID: 38986041
Purpose: This study aimed to define genomic differences between perihilar cholangiocarcinoma (PCA) and distal cholangiocarcinoma (DCA) and identify genomic determinants of survival. Materials And Methods: Consecutive patients with ECA with...
20.
Zhao K, Son S, Karimi A, Marinelli B, Erinjeri J, Alexander E, et al.
Curr Oncol
. 2024 May;
31(5):2650-2661.
PMID: 38785481
The aim of this study was to evaluate outcomes of transarterial radioembolization (TARE) for hepatocellular carcinoma (HCC) in patients previously treated with transarterial embolization (TAE). In this retrospective study, all...